Potent Therapeutic Activity of NEO212 in Preclinical Models of Human and Canine Leukaemia and Lymphoma is a research paper published in Veterinary and Comparative Oncology (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA014089
NeOnc Technologies, Inc.
NeOnc Technologies, Inc.
FWCI
0.00
Citation Percentile
0.1%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals